“…In most trials, the length of intervention and the length of follow-up were similar, with only five trials reporting a few months' difference between the end of the intervention and hemoglobin A 1C assessment. 21,23,29,39,49 Most of the studies (29 trials) focused solely on type 2 diabetes, 9 included patients with either type 1 or 2 diabetes, and 3 trials focused on type 1 diabetes. The mean age of the participants was 57.6 years (SD 7.3); 46.0% were men.…”